Larvol Delta - Transarterial-chemoembolization-TACE-combined-with-Camrelizumab-and-Apatinib-versus-camrelizumab-and-apatinib-in-the-treatment-of-unresectable-hepatocellular-carcinoma--A-multicenter-openlabel-randomized-trial

AiTan (rivoceranib) - Elevar Therapeutics

AiRuiKa (camrelizumab) - Elevar Therapeutics

https://cslide.ctimeetingtech.com/esmo2026/attendee/confcal_2/print/presentation/7616

Xuegang Yang; Guohui Xu

Jul 17, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next